Grow Your Wealth
with Mutual Funds
Lic Mf Healthcare Fund Direct-growth
Equity
Mid Cap
Very High Risk
Latest AUM
₹ 92.5 Cr.
NAV as on 03 aug, 2026
₹ 36.88
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
Lic Mf Healthcare Fund Direct-growth
Inception Date
28 Feb 2019
Lock In
No Lock-in
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
95.19%
Cash
4.81%
Portfolio Updated on: 10 Jul, 2026
Sector Allocations
Equity
Healthcare
Materials
Portfolio Updated on: 03 aug, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.47% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.55% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.55% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.22% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.61% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.77% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.09% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.39% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.39% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.85% |
Debt & Credit Risk Analysis
| Alpha | -0.01% |
| Beta | 0.94% |
| R2 | 0.93% |
| Sharpe Ratio | 0.97% |
| Standard Deviation | 15.85% |
| Sortino Ratio | 1.47% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 13.99% | NA | 6.12% |
| 6 Months | 20.83% | NA | 12.92% |
| 9 Months | 11.41% | NA | 4.47% |
| 1 Year | 14.47% | 14.47% | 6.04% |
| 2 Years | 24.68% | 11.66% | 24.93% |
| 3 Years | 80.87% | 21.84% | 25.71% |
| 5 Years | 79.88% | 12.46% | 19.91% |
| 7 Years | 278.00% | 20.92% | NA |
Lic Mf Healthcare Fund Direct-growth is one Equity mutual fund offered by LIC Mutual Fund. Launched on 28 Feb 2019, the fund aims Long term Capital appreciation. Investment predominantly in equity and equity related instruments of companies engaged in Healthcare & Allied Sectors. It manages assets worth ₹92.5 crore as on Tue Jun 30, 2026. The expense ratio stands at 1.42%.
Karan Doshi has experience Prior to joining LIC Mutual Fund, he has worked with Subhkam Ventures Pvt. Limited as Equity Analyst.
Top Performing Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,997.7 | +2.81% | +17.48% | +25.25% | +20.07% | +24.60% | +17.98% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,997.7 | +2.81% | +17.48% | +25.25% | +20.07% | +24.60% | +17.98% |
| SBI Healthcare Opportunities Fund-growth | 4,997.7 | +2.72% | +17.19% | +24.63% | +18.87% | +23.32% | +16.75% |
| SBI Healthcare Opportunities Fund-idcw | 4,997.7 | +2.72% | +17.19% | +24.63% | +18.87% | +23.32% | +16.75% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,624.6 | +0.97% | +10.20% | +15.47% | +10.98% | +24.03% | +16.63% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,624.6 | +0.97% | +10.20% | +15.47% | +10.98% | +24.03% | +16.63% |
| DSP Healthcare Fund Direct-growth | 3,514.0 | +2.43% | +13.63% | +18.99% | +10.81% | +21.00% | +15.99% |
| DSP Healthcare Fund Direct-idcw | 3,514.0 | +2.43% | +13.63% | +18.99% | +10.81% | +21.00% | +15.99% |
| Mirae Asset Healthcare Fund Direct-growth | 3,252.5 | +3.07% | +14.10% | +24.01% | +19.66% | +23.87% | +15.83% |
| Mirae Asset Healthcare Fund Direct-idcw | 3,252.5 | +3.07% | +14.10% | +24.01% | +19.66% | +23.87% | +15.83% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from LIC Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Lic Mf Healthcare Fund Regular-growth | 92.5 | +2.99% | +13.61% | +20.00% | +12.98% | +20.34% | +11.07% |
| Lic Mf Healthcare Fund Regular-idcw | 92.5 | +2.99% | +13.61% | +20.00% | +12.98% | +20.34% | +11.07% |
| Lic Mf Healthcare Fund Direct-idcw | 92.5 | +3.10% | +13.99% | +20.83% | +14.47% | +21.84% | +12.46% |
growth is based on 1-month returns of the funds
Top Mutual Funds
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹595.67 | +24.60% | +17.98% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹413.85 | +24.60% | +17.98% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹514.75 | +23.32% | +16.75% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹324.27 | +23.32% | +16.75% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹47.77 | +24.03% | +16.63% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.85 | +24.03% | +16.63% | — |
| Dsp Healthcare Fund Direct-growth | ₹49.33 | +21.00% | +15.99% | — |
| Dsp Healthcare Fund Direct-idcw | ₹28.53 | +21.00% | +15.99% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹51.65 | +23.87% | +15.83% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹31.11 | +23.87% | +15.83% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 03 Aug 2026 | ₹36.88 |
| 31 Jul 2026 | ₹36.70 |
| 30 Jul 2026 | ₹36.59 |
| 29 Jul 2026 | ₹36.82 |
| 28 Jul 2026 | ₹36.22 |
| 27 Jul 2026 | ₹36.23 |
| 24 Jul 2026 | ₹35.74 |
| 23 Jul 2026 | ₹35.89 |
| 22 Jul 2026 | ₹36.08 |
| 21 Jul 2026 | ₹36.41 |
| 20 Jul 2026 | ₹36.33 |
| 17 Jul 2026 | ₹35.84 |
| 16 Jul 2026 | ₹36.33 |
| 15 Jul 2026 | ₹36.37 |
| 14 Jul 2026 | ₹36.13 |
| 13 Jul 2026 | ₹35.92 |
| 10 Jul 2026 | ₹35.99 |
| 09 Jul 2026 | ₹35.88 |
| 08 Jul 2026 | ₹35.30 |
| 07 Jul 2026 | ₹35.72 |
| 06 Jul 2026 | ₹35.95 |
| 03 Jul 2026 | ₹35.78 |
| 02 Jul 2026 | ₹35.34 |
| 01 Jul 2026 | ₹35.06 |
| 30 Jun 2026 | ₹35.19 |
| 29 Jun 2026 | ₹34.87 |
| 25 Jun 2026 | ₹34.69 |
| 24 Jun 2026 | ₹34.81 |
| 23 Jun 2026 | ₹34.72 |
| 22 Jun 2026 | ₹34.49 |
Portfolio Updated on: 04 Aug, 2026
Fund Growth & Size Analysis
+₹92.5 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
Lic Mf Healthcare Fund Direct-growth Returns Comparison
Compare Lic Mf Healthcare Fund Direct-growth with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
Lic Mf Healthcare Fund....
No funds found for your search.
Lic Mf Healthcare Fund Direct-growth FAQ'S
- Sharpe Ratio: 0.97%
- Standard Deviation: 15.85%
- Beta: 0.94%
- Alpha: -0.01%
- R-squared: 0.93%
- Information Ratio: -0.24%
- Sortino Ratio: 1.47%
Additional important ratios:
As of Tue Jun 30, 2026, the total assets managed under Lic Mf Healthcare Fund Direct-growth stand at approximately ₹ 92.5 crore.
The Lic Mf Healthcare Fund Direct-growth has delivered the following short-term performance:
- 3 Months Return: 13.99%
- 6 Months Return: 20.83%
The historical growth of the Lic Mf Healthcare Fund Direct-growth is reflected through its CAGR returns:
- 3 Year CAGR: 21.84%
- 5 Year CAGR: 12.46%
- Return Since Launch: 19.20%
The portfolio of Lic Mf Healthcare Fund Direct-growth is distributed across different asset classes as follows:
- Equity: 95.19%
- Other Assets: 4.81%
The Lic Mf Healthcare Fund Direct-growth is managed by Karan Doshi, representing LIC Mutual Fund.
The Lic Mf Healthcare Fund Direct-growth investments are allocated across market caps in the following manner:
- Large Cap Stocks: 32.61%
- Mid Cap Stocks: 35.01%
- Small Cap Stocks: 32.38%
Top stock holdings of Lic Mf Healthcare Fund Direct-growth include:
- Sun Pharmaceutical Industries Ltd – represents 11.47% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.55% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.55% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.22% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.61% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.77% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.09% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.39% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.39% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.85% of the portfolio
Major sector exposures in Lic Mf Healthcare Fund Direct-growth are:
- Healthcare – accounts for 1,179.45% of the portfolio
- Materials – accounts for 68.59% of the portfolio
